Return On Assets of Coherus Oncology, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Coherus Oncology, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Coherus Oncology, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 35%.
  • Coherus Oncology, Inc. annual Return On Assets for 2024 was 4.8%.
  • Coherus Oncology, Inc. annual Return On Assets for 2023 was -46%, a 15% increase from 2022.
  • Coherus Oncology, Inc. annual Return On Assets for 2022 was -54%, a 34% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Coherus Oncology, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 35% +35% 01 Jul 2025 30 Sep 2025
Q2 2025 41% +45% 01 Apr 2025 30 Jun 2025
Q1 2025 -26% -16% -170% 01 Jan 2025 31 Mar 2025
Q4 2024 4.8% +50% 01 Oct 2024 31 Dec 2024
Q3 2024 -0.07% +45% +100% 01 Jul 2024 30 Sep 2024
Q2 2024 -4.4% +51% +92% 01 Apr 2024 30 Jun 2024
Q1 2024 -9.7% +45% +82% 01 Jan 2024 31 Mar 2024
Q4 2023 -46% +8.1% +15% 01 Oct 2023 31 Dec 2023
Q3 2023 -45% +2.2% +4.7% 01 Jul 2023 30 Sep 2023
Q2 2023 -55% -19% -54% 01 Apr 2023 30 Jun 2023
Q1 2023 -55% -24% -80% 01 Jan 2023 31 Mar 2023
Q4 2022 -54% -14% -34% 01 Oct 2022 31 Dec 2022
Q3 2022 -47% -16% -53% 01 Jul 2022 30 Sep 2022
Q2 2022 -36% -15% -68% 01 Apr 2022 30 Jun 2022
Q1 2022 -31% -21% -210% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% -59% -318% 01 Oct 2021 31 Dec 2021
Q3 2021 -31% -57% -216% 01 Jul 2021 30 Sep 2021
Q2 2021 -21% -58% -158% 01 Apr 2021 30 Jun 2021
Q1 2021 -9.9% -50% -124% 01 Jan 2021 31 Mar 2021
Q4 2020 18% -12% -40% 01 Oct 2020 31 Dec 2020
Q3 2020 27% +32% 01 Jul 2020 30 Sep 2020
Q2 2020 37% +108% 01 Apr 2020 30 Jun 2020
Q1 2020 40% +161% 01 Jan 2020 31 Mar 2020
Q4 2019 31% +181% 01 Oct 2019 31 Dec 2019
Q3 2019 -5.6% +121% +96% 01 Jul 2019 30 Sep 2019
Q2 2019 -71% +47% +40% 01 Apr 2019 30 Jun 2019
Q1 2019 -120% +6.9% +5.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -150% -23% -19% 01 Oct 2018 31 Dec 2018
Q3 2018 -126% +12% +8.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -117% -54% -85% 01 Apr 2018 30 Jun 2018
Q1 2018 -127% -63% -98% 01 Jan 2018 31 Mar 2018
Q4 2017 -127% -67% -111% 01 Oct 2017 31 Dec 2017
Q3 2017 -138% -91% -193% 01 Jul 2017 30 Sep 2017
Q2 2017 -63% +53% +45% 01 Apr 2017 30 Jun 2017
Q1 2017 -64% +47% +42% 01 Jan 2017 31 Mar 2017
Q4 2016 -60% +49% +45% 01 Oct 2016 31 Dec 2016
Q3 2016 -47% +54% +53% 01 Jul 2016 30 Sep 2016
Q2 2016 -116% -40% -53% 01 Apr 2016 30 Jun 2016
Q1 2016 -111% 01 Jan 2016 31 Mar 2016
Q4 2015 -109% 01 Oct 2015 31 Dec 2015
Q3 2015 -101% 01 Jul 2015 30 Sep 2015
Q2 2015 -76% 01 Apr 2015 30 Jun 2015

Coherus Oncology, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 4.8% +50% 01 Jan 2024 31 Dec 2024
2023 -46% +8.1% +15% 01 Jan 2023 31 Dec 2023
2022 -54% -14% -34% 01 Jan 2022 31 Dec 2022
2021 -40% -59% -318% 01 Jan 2021 31 Dec 2021
2020 18% -12% -40% 01 Jan 2020 31 Dec 2020
2019 31% +181% 01 Jan 2019 31 Dec 2019
2018 -150% -23% -19% 01 Jan 2018 31 Dec 2018
2017 -127% -67% -111% 01 Jan 2017 31 Dec 2017
2016 -60% +49% +45% 01 Jan 2016 31 Dec 2016
2015 -109% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.